Questran (cholestyramine) Cholestyramine, when taken alongside spironolactone, may cause people to experience an imbalance in their blood chemistry, known as hyperkalemic metabolic acidosis
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be considered as an adjunct to lifestyle therapy in all patients with T2DM as needed for weight loss sufficient to improve glycemic control, lipids, and blood pressure
If you've ever found yourself staring at your reflection, wondering about those mysterious spots that appear on your skin, you're not alone
We also offer in-office injections at our Nashville and Memphis locations for those who prefer professional administration
Phase 3 results will be critical for determining whether monthly GLP-1 dosing delivers on its promise
Castejn ML, Rosillo M, Montoya T, Gonzlez-Benjumea A, Fernndez-Bolaos JM, Alarcn-de-la-Lastra C
